Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop : Effect on cultured human conjunctival goblet cells and their physicochemical properties. / Hedengran, Anne; Freiberg, Josefine Clement; Hansen, Pernille May; Jacobsen, Jette; Larsen, Susan Weng; Harloff‐helleberg, Stine; Freude, Kristine; Boix‐lemonche, Gerard; Petrovski, Goran; Heegaard, Steffen; Kolko, Miriam.

In: Acta Ophthalmologica, Vol. 100, No. 7, 2022, p. 819-827.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hedengran, A, Freiberg, JC, Hansen, PM, Jacobsen, J, Larsen, SW, Harloff‐helleberg, S, Freude, K, Boix‐lemonche, G, Petrovski, G, Heegaard, S & Kolko, M 2022, 'Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties', Acta Ophthalmologica, vol. 100, no. 7, pp. 819-827. https://doi.org/10.1111/aos.15163

APA

Hedengran, A., Freiberg, J. C., Hansen, P. M., Jacobsen, J., Larsen, S. W., Harloff‐helleberg, S., Freude, K., Boix‐lemonche, G., Petrovski, G., Heegaard, S., & Kolko, M. (2022). Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties. Acta Ophthalmologica, 100(7), 819-827. https://doi.org/10.1111/aos.15163

Vancouver

Hedengran A, Freiberg JC, Hansen PM, Jacobsen J, Larsen SW, Harloff‐helleberg S et al. Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties. Acta Ophthalmologica. 2022;100(7):819-827. https://doi.org/10.1111/aos.15163

Author

Hedengran, Anne ; Freiberg, Josefine Clement ; Hansen, Pernille May ; Jacobsen, Jette ; Larsen, Susan Weng ; Harloff‐helleberg, Stine ; Freude, Kristine ; Boix‐lemonche, Gerard ; Petrovski, Goran ; Heegaard, Steffen ; Kolko, Miriam. / Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop : Effect on cultured human conjunctival goblet cells and their physicochemical properties. In: Acta Ophthalmologica. 2022 ; Vol. 100, No. 7. pp. 819-827.

Bibtex

@article{a44cc3d6da2342eca25fb16705f240e8,
title = "Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties",
abstract = "PurposeTo investigate the effect of polyquaternium-1 (PQ)-preserved and benzalkonium chloride (BAK)-preserved travoprost eye drops on viability of primary human conjunctival goblet cell (GC) cultures and on secretion of mucin and cytokines. Furthermore, to evaluate the physicochemical properties of the branded travoprost eye drop Travatan{\textregistered} and available generics.MethodsThe effect of travoprost eye drops was evaluated on GC cultures. Cell viability was assessed through lactate dehydrogenase (LDH) and tetrazolium dye (MTT) colorimetric assays. Mucin secretion was evaluated by immunohistochemical staining. Secretion of interleukin (IL)-6 and IL-8 was measured using BD Cytometric Bead Arrays. pH, viscosity, droplet mass, osmolality and surface tension were measured for all included eye drops.ResultsIn the LDH assay, BAK travoprost caused significant GC loss after 2 hrs of incubation compared to the control. PQ travoprost caused no GC loss at any time point. Both PQ- and BAK travoprost caused secretion of mucin to the cytoplasma. No difference in IL-6 and IL-8 secretion was identified compared to controls. The pH values for the generics were lower (pH 6.0) than the pH value for Travatan (pH 6.7; p < 0.0001). The viscosity was lowest for Travatan, while the mean droplet mass was higher for Travatan (35 mg) than the generics (28–30 mg; p ≤ 0.0318). The osmolality and surface tension did not differ between the eye drops investigated.ConclusionBAK travoprost caused GC loss, indicating that PQ preservation may be preferable in treatment of glaucoma. Furthermore, physicochemical properties of branded and generic travoprost eye drops can not be assumed to be identical.",
author = "Anne Hedengran and Freiberg, {Josefine Clement} and Hansen, {Pernille May} and Jette Jacobsen and Larsen, {Susan Weng} and Stine Harloff‐helleberg and Kristine Freude and Gerard Boix‐lemonche and Goran Petrovski and Steffen Heegaard and Miriam Kolko",
year = "2022",
doi = "10.1111/aos.15163",
language = "English",
volume = "100",
pages = "819--827",
journal = "Acta Ophthalmologica",
issn = "1755-375X",
publisher = "Wiley-Blackwell",
number = "7",

}

RIS

TY - JOUR

T1 - Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop

T2 - Effect on cultured human conjunctival goblet cells and their physicochemical properties

AU - Hedengran, Anne

AU - Freiberg, Josefine Clement

AU - Hansen, Pernille May

AU - Jacobsen, Jette

AU - Larsen, Susan Weng

AU - Harloff‐helleberg, Stine

AU - Freude, Kristine

AU - Boix‐lemonche, Gerard

AU - Petrovski, Goran

AU - Heegaard, Steffen

AU - Kolko, Miriam

PY - 2022

Y1 - 2022

N2 - PurposeTo investigate the effect of polyquaternium-1 (PQ)-preserved and benzalkonium chloride (BAK)-preserved travoprost eye drops on viability of primary human conjunctival goblet cell (GC) cultures and on secretion of mucin and cytokines. Furthermore, to evaluate the physicochemical properties of the branded travoprost eye drop Travatan® and available generics.MethodsThe effect of travoprost eye drops was evaluated on GC cultures. Cell viability was assessed through lactate dehydrogenase (LDH) and tetrazolium dye (MTT) colorimetric assays. Mucin secretion was evaluated by immunohistochemical staining. Secretion of interleukin (IL)-6 and IL-8 was measured using BD Cytometric Bead Arrays. pH, viscosity, droplet mass, osmolality and surface tension were measured for all included eye drops.ResultsIn the LDH assay, BAK travoprost caused significant GC loss after 2 hrs of incubation compared to the control. PQ travoprost caused no GC loss at any time point. Both PQ- and BAK travoprost caused secretion of mucin to the cytoplasma. No difference in IL-6 and IL-8 secretion was identified compared to controls. The pH values for the generics were lower (pH 6.0) than the pH value for Travatan (pH 6.7; p < 0.0001). The viscosity was lowest for Travatan, while the mean droplet mass was higher for Travatan (35 mg) than the generics (28–30 mg; p ≤ 0.0318). The osmolality and surface tension did not differ between the eye drops investigated.ConclusionBAK travoprost caused GC loss, indicating that PQ preservation may be preferable in treatment of glaucoma. Furthermore, physicochemical properties of branded and generic travoprost eye drops can not be assumed to be identical.

AB - PurposeTo investigate the effect of polyquaternium-1 (PQ)-preserved and benzalkonium chloride (BAK)-preserved travoprost eye drops on viability of primary human conjunctival goblet cell (GC) cultures and on secretion of mucin and cytokines. Furthermore, to evaluate the physicochemical properties of the branded travoprost eye drop Travatan® and available generics.MethodsThe effect of travoprost eye drops was evaluated on GC cultures. Cell viability was assessed through lactate dehydrogenase (LDH) and tetrazolium dye (MTT) colorimetric assays. Mucin secretion was evaluated by immunohistochemical staining. Secretion of interleukin (IL)-6 and IL-8 was measured using BD Cytometric Bead Arrays. pH, viscosity, droplet mass, osmolality and surface tension were measured for all included eye drops.ResultsIn the LDH assay, BAK travoprost caused significant GC loss after 2 hrs of incubation compared to the control. PQ travoprost caused no GC loss at any time point. Both PQ- and BAK travoprost caused secretion of mucin to the cytoplasma. No difference in IL-6 and IL-8 secretion was identified compared to controls. The pH values for the generics were lower (pH 6.0) than the pH value for Travatan (pH 6.7; p < 0.0001). The viscosity was lowest for Travatan, while the mean droplet mass was higher for Travatan (35 mg) than the generics (28–30 mg; p ≤ 0.0318). The osmolality and surface tension did not differ between the eye drops investigated.ConclusionBAK travoprost caused GC loss, indicating that PQ preservation may be preferable in treatment of glaucoma. Furthermore, physicochemical properties of branded and generic travoprost eye drops can not be assumed to be identical.

U2 - 10.1111/aos.15163

DO - 10.1111/aos.15163

M3 - Journal article

C2 - 35527390

VL - 100

SP - 819

EP - 827

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-375X

IS - 7

ER -

ID: 305403668